Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
Cancer is leading cause of death in Japan. It is known that the metastasis has occurred in most cases of death. There is no method to find the metastasis at an early stage. Therefore, a low-cost, easy-to-use, and high-sensitive cancer metastasis screening method is required. Initiation metastasis required invasion, which is enabled by epithelial-mesenchymal transition(EMT). Here, we detected the biomarker candidates for metastasis using EMT-induced breast cancer cells.
|